Vantage logo

Macrogenics scoops its Asco bounce

A tiny glimpse at very early data has more than tripled Macrogenics’ market cap. The pressure is now on to confirm these signals.

Vantage logo

Rubius confirms the worst

The collapse of Rubius’s first attempt to demonstrate the worth of its red blood cell platform proves that this company should never have gone public.